Leading Cardio-Diabetes and Primary care division of Getz pharma, managing a portfolio of PKR 4.8 Bio (Approx 43 Mio USDs).

Led the teams of Cardio-Metabolic and Primary care portfolio valued around USD 30 Mio (PKR 3 Bio). leading many flagship brands of Getz Pharma. Six of the these top brands are also leading their therapeutic class.

Starting up business for associates and clients.Leading / consultation for various set-ups like Neutraceuticals, Health services and event management primarily for Pharmaceuticals.

RESPONSIBILITIES:• Responsible for driving strategy and leading Speciality portfolio of Pfizer Pakistan valued around approx 16 Mio USD (PKR 1.6 Bio).• The portfolio resolves around six major TAs Including CNS, Oncology, Anti Infectives, Urogynae, Women health and Ophthalmology• Personally involved in Training and development of my CPMs and Sales team specially Tygacil team. (In order to prepare team for a significant growth in budget).• People Management of a diversified team… Show more RESPONSIBILITIES:• Responsible for driving strategy and leading Speciality portfolio of Pfizer Pakistan valued around approx 16 Mio USD (PKR 1.6 Bio).• The portfolio resolves around six major TAs Including CNS, Oncology, Anti Infectives, Urogynae, Women health and Ophthalmology• Personally involved in Training and development of my CPMs and Sales team specially Tygacil team. (In order to prepare team for a significant growth in budget).• People Management of a diversified team of 4 CPMs along with trainee employees.• Responsible for effective Life Cycle and LOE (Loss of exclusivity) management strategies on the brands.• Managing Pfizer Pakistan’s promotional material activity and ware house.ACHIEVEMENTS:• Tygacil Regional Reward on plan to revive Tygacil in Pakistan. This reward of 158,000 USD was utilized to deliver the growth and revenues over and above decided OP revenue. (Estimate of unit increase from 3000 - 20,000 in 2015)• Implementation of online tracking system for promotional material (Supply me) Pfizer Pakistan will be first country to launch the system in Asia.• Compliance champion – Pfizer Pakistan Marketing Show less

RESPONSIBILITIES:• Responsible for driving strategy and leading this portfolio of approx 30 Mio USD (PKR 3.2 Bio) with all range of oral and injectable Anti infective agents.• People Management of a diversified team of 3 CPMs along with management trainees.• Handling marketing aspect of Afghan export business for Pfizer Pakistan, mainly Anti infectives, Pain and CV(Value Approx 8 Mio USD)• Managing Pfizer Pakistan’s promotional material ware house and a ware house manager along… Show more RESPONSIBILITIES:• Responsible for driving strategy and leading this portfolio of approx 30 Mio USD (PKR 3.2 Bio) with all range of oral and injectable Anti infective agents.• People Management of a diversified team of 3 CPMs along with management trainees.• Handling marketing aspect of Afghan export business for Pfizer Pakistan, mainly Anti infectives, Pain and CV(Value Approx 8 Mio USD)• Managing Pfizer Pakistan’s promotional material ware house and a ware house manager along with his team reporting into me for the same.• Active member of Retail strategy team of PfizerACHIEVEMENTS:• Led the formation of Myrin Specialty team (Value Approx 10 Mio USD) showing positive trend in growth within 6 months.• Deltacortril revamping, the brand achievement is 107% and is showing a high double digit growth after 1 year (Brand value Approx 2.2 Mio USD)• Training and development of Team Philippines and regional team on TB and dynamics of improving business.• First ever Regional alliance to control TB. • TB Education Website and country wide TB clinics.• Development of local guidelines to manage infections in collaboration with IDSP (Infectious Disease society of Pakistan) Show less

RESPONSIBILITIES:• Effectively lead and manage one of the most diversified and strategic portfolio with a value of Approx 9 Mio USD, including brands such as:● Prevenar 13 ● Detrusitol ● Tygacil● Enbrel ● Lyrica ● Zeldox● Xalabrands ● Premarin ● Sutent ● Aromasin• People Management of 3 Brand managers with diversified background and cultures• Responsible for effective Life Cycle and LOE (Loss of exclusivity) management strategies on the… Show more RESPONSIBILITIES:• Effectively lead and manage one of the most diversified and strategic portfolio with a value of Approx 9 Mio USD, including brands such as:● Prevenar 13 ● Detrusitol ● Tygacil● Enbrel ● Lyrica ● Zeldox● Xalabrands ● Premarin ● Sutent ● Aromasin• People Management of 3 Brand managers with diversified background and cultures• Responsible for effective Life Cycle and LOE (Loss of exclusivity) management strategies on the brands.• Support the team in devising long term and short term strategies to drive the growth and capture the market share.• Supporting brand managers in setting up the right promotional mix for their brands as per the need and requirement of the brand• Aligning the portfolio with local and regional priorities• Developing forecast and strategic outlook for all new upcoming Pharma brands like:● Xalkori ● Eliquis ● Inlyta ACHIEVEMENTS:• Maintained more than 80% share of prescription in private market even though strong competition from Synflorix emerged as GSK vaccine was included in EPI program• Roll out and training of sales team on New selling model i.e. CFSA (Customer focused selling approach).• Shifting of focus from IDS and Microbiologists to Surgeons supported in highest achievement ever of 107%• Increased share of Rx in Urologists as a result of Urology focused activities and Urology documentary drama to highlight the social problems tagged with OAB (Ach of more than 100%)• Creating effective synergy b/w AI specialty and EP portfolios.• Lyrica new indication launch in Fibromyalgia with around 3% penetration at the time of launch• Total portfolio achievement was 100% with a growth of around 11% Show less

RESPONSIBILITIES:• Managed most strategic Specialty and CV brands with a value of Approx 3.5 Mio USD, including brands such as:●Lipitor ●Caduet ●Lyrica ● Sutent ● Prevenar 13 (Additional responsibility)●Chantix ●Campto• Responsible for involving sales team in creative product information and training sessions• Responsible for various ATL / BTL activities on the concerned brands• Achieve annual budget sales and profitability of responsible… Show more RESPONSIBILITIES:• Managed most strategic Specialty and CV brands with a value of Approx 3.5 Mio USD, including brands such as:●Lipitor ●Caduet ●Lyrica ● Sutent ● Prevenar 13 (Additional responsibility)●Chantix ●Campto• Responsible for involving sales team in creative product information and training sessions• Responsible for various ATL / BTL activities on the concerned brands• Achieve annual budget sales and profitability of responsible products• Maintaining the right ratio promotional mix including CMEs, Symposia, Local, international meetings and speaker road shows• Implementing team engagement some of the initiatives are Star wars workshop, Pakistan CV Race and CV Innovation ChampionshipACHIEVEMENTS:• Successful Launch of Aromasin in Pakistan ER+ Breast Cancer Market• Successful repositioning of Lipitor amongst Cardiologists, Physicians, Endocrinologists and Neurologists• Revolutionizing the concept of cardio care to Cardio Metabolic Care in order to align the portfolio with unmet market needs.• Improving both internal sales and IMS ranking of Lipitor in a market with fierce generic competition achieving highest ever growth of 21% (QTR)Q4 – 2012• Regional recognition of Lipitor’s 360 degree approach marketing in 2012• Develop Pfizer Pakistan’s first ever interactive detailing tool on CV and Oncology brands• Launch of first ever Local Depression management guidelines Show less

ACHIEVEMENTS:• Active country member for ACT (Area commercial team) on the concerned brands• Launch of first ever Hypertension management guidelines• Successful Relaunch of Solucortef

• Worked as an Assistant Product Manager in the CV &Diabetes division• Responsible for major strategic brands such as Lipiget (Valued at 3 Mio USD, biggest generic competitor for Lipitor and the market leader), Zolid and its combinations (Pioglitazone, value USD 2 Mio), Advant (Candesartan, Value USD 2 Mio) and Trupril(Lisinopril).• Successfully Launched ZOLIGET (combination of Pioglitazone and Glimepride)• Developed Launch feasibility of Dermatology portfolio including Rx and OTC… Show more • Worked as an Assistant Product Manager in the CV &Diabetes division• Responsible for major strategic brands such as Lipiget (Valued at 3 Mio USD, biggest generic competitor for Lipitor and the market leader), Zolid and its combinations (Pioglitazone, value USD 2 Mio), Advant (Candesartan, Value USD 2 Mio) and Trupril(Lisinopril).• Successfully Launched ZOLIGET (combination of Pioglitazone and Glimepride)• Developed Launch feasibility of Dermatology portfolio including Rx and OTC Derma Brands.ACHIEVEMENT:• Significant increase in growth of Lipiget from 19% - 24 %(IMS Q1 2008 – IMS Q1 2009)• Development of a new customer base in GPs in rural areas leveraging on CARDS study• Successful Launch of Line extension of Zolid (Pioglitazone) by the name of Zoliget (Pioglitazone&Glimepride)• More than 100 % achievement on year end. Show less

• Started career in Sanofi-Aventis as Aprovel Task Manager for pre-launch, launch and Post launch marketing campaign of Aprovel and Co Aprovel.• Development and launch of National guidelines for the management of STEMI (ST-Elevation Myocardial Infarction) through platform of Sanofi-Aventis.• Roll out of patient registry initiative HEART-Asia (Hypertension Evaluation and Recommended Treatment in Asia)